Antisense oligonucleotides and ribozymes have shown promise both as antimalarial agents and as tools for identifying genes vital for parasite survival. This task is urgent due to the ineffectiveness of current drug regimes on the most virulent human malarial parasite, Plasmodium falciparum. The development of new ways to modify and/or protect conventional phosphodiester oligonucleotides to improve nuclease resistance is also important. We assessed the effect of antisense oligonucleotides containing phosphorylated anhydrohexitols in suppressing the growth of P. falciparum in culture. The modified oligonucleotides were able to inhibit parasite growth in a sequence-specific manner, but not as well as the phosphorothioated antisense oligonucleo...
The appearance of multi-drug resistant strains of malaria poses a major challenge to human health an...
Techniques for targeted genetic disruption in <i>Plasmodium</i>, the causative agent of ...
Techniques for targeted genetic disruption in <i>Plasmodium</i>, the causative agent of ...
Comparative biochemical studies between the malaria parasite, Plasmodium falciparum, and its host ha...
We investigated about targeting for new antimalarial drugs using antisense (AS) oligodeoxynucleotide...
One of the major concerns in treating malaria by conventional small drug molecules is the rapid emer...
The malarial parasite Plasmodium falciparum depends on the purine salvage enzyme hypoxanthine-guanin...
Malaria remains one of the world's most devastating infectious diseases. Drug resistance to all clas...
Malaria remains the most serious parasitic diseases affecting humans in the world today, resulting i...
The vision of a malaria-free world is threatened by antimalarial drug resistance. For malaria elimin...
Techniques for targeted genetic disruption in Plasmodium, the causative agent of malaria, are curren...
Two lines of research were followed to obtain an adequate antisense effect. Natural oligonucleotides...
The recent advances in genomic sequencing technologies in the past decade have enabled the unprecede...
Parasites in the genus Plasmodium cause disease throughout the tropic and subtropical regions of the...
The major problem facing world research for new antimalarials lies in encountered difficulties in th...
The appearance of multi-drug resistant strains of malaria poses a major challenge to human health an...
Techniques for targeted genetic disruption in <i>Plasmodium</i>, the causative agent of ...
Techniques for targeted genetic disruption in <i>Plasmodium</i>, the causative agent of ...
Comparative biochemical studies between the malaria parasite, Plasmodium falciparum, and its host ha...
We investigated about targeting for new antimalarial drugs using antisense (AS) oligodeoxynucleotide...
One of the major concerns in treating malaria by conventional small drug molecules is the rapid emer...
The malarial parasite Plasmodium falciparum depends on the purine salvage enzyme hypoxanthine-guanin...
Malaria remains one of the world's most devastating infectious diseases. Drug resistance to all clas...
Malaria remains the most serious parasitic diseases affecting humans in the world today, resulting i...
The vision of a malaria-free world is threatened by antimalarial drug resistance. For malaria elimin...
Techniques for targeted genetic disruption in Plasmodium, the causative agent of malaria, are curren...
Two lines of research were followed to obtain an adequate antisense effect. Natural oligonucleotides...
The recent advances in genomic sequencing technologies in the past decade have enabled the unprecede...
Parasites in the genus Plasmodium cause disease throughout the tropic and subtropical regions of the...
The major problem facing world research for new antimalarials lies in encountered difficulties in th...
The appearance of multi-drug resistant strains of malaria poses a major challenge to human health an...
Techniques for targeted genetic disruption in <i>Plasmodium</i>, the causative agent of ...
Techniques for targeted genetic disruption in <i>Plasmodium</i>, the causative agent of ...